Impact of somatic gene mutations on response to lenalidomide in MDS patients
Information is key: why patients need to be empowered to learn about their disease
Acalabrutinib for the treatment of Richter's transformation and patients with ibrutinib intolerance
The 20th anniversary of the German CLL Study Group and the importance of collaboration
How do targeted treatments for IDH1 and IDH2 mutations work in acute myeloid leukemia (AML)?